Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

During the study, participants are asked to continue their usual diabetes therapy and any other medication prescribed by you or other doctors. If it is necessary to commence a GLP-1 receptor agonist as part of your patient’s usual diabetes treatment, then the ASCEND PLUS team should be informed and the randomised study treatment will be discontinued. You patient will continue the trial follow-up procedures.